Delivery Order SPE2DX22D0010-SPE2D826FBN62
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $1,267.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix Tablets 5MG, with an ultimate completion date of August 1, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. The award was issued to AmerisourceBergen's Corporate Office division, with performance taking place at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Amphetamine Mix Tablets 20mg, valued at $1,989.00. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix Tabs 5mg under a firm fixed price contract with a ceiling value of $1,381.04. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $2,564.06 to provide amphetamine mix tablets (5mg) with a completion date of February 23, 2024. This delivery order is part of an indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply a wide range of pharmaceutical products and medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,217.90 for 100 tablets of Amphetamine 20mg from the Defense Logistics Agency's Medical Supply Chain on October 14, 2025, with completion targeted for October 15, 2025. This delivery order is issued under a firm fixed-price arrangement with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Amphetamine Mix Tablets 20mg, valued at $1,247.04. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for amphetamine mix tablets (20mg) on November 13, 2025, with a contract ceiling value of $4,987.68 and an ultimate completion date of November 14, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Amphetamine Mix Tablets 5mg, with a contract ceiling value of $1,080.39 and an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a single-line pharmaceutical supply action under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,408.02 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25 mg, with a completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare systems....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,791.98 to AmerisourceBergen Drug Corp for Amphetamine Mix Tablets 5mg on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This award represents a small-value transaction within...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBN62Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for amphetamine mix tablets (20mg) under a firm fixed-price contract valued at $1,708.56. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of December 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and operates under a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order represents a routine pharmaceutical supply transaction supporting military and federal healthcare operations. AmerisourceBergen's role as a prime vendor for the DLA Medical Supply Chain reflects its established capability to supply a comprehensive range of pharmaceutical products, including controlled substances and specialty medications, to support defense health initiatives. The company's federal contract portfolio demonstrates consistent performance in fulfilling competitive procurement requirements across multiple therapeutic domains, positioning it as a key supplier for the Defense Health Agency and related military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/4/25 |